NCP 2.0 Repeat Study

Status Completed

Clinical Trial Summary

The NeuroCatch Platform™ version 2.0 (NCP2.0), an investigational medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provide a quick, portable and easy to use solution for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and event-related potential (ERP; brain response to a stimulus) information. The purpose of the study is to understand how reliable and repeatable the ERP metrics elicited by the NCP platform are within participants over multiple sessions.

Clinical Trial Description

A new method for creating stimulus sequences was developed for NeuroCatch™ Platform 2.0. Rather than using a set of fixed, predetermined sequences to elicit ERPs this new method draws on a database of candidate word stimuli to generate a different, random stimulus sequence each time a scan is carried out. The goal of this is to reduce habituation to the stimulus sequences which is hypothesized to improve the repeatability of the component measurements. Characterizing how individuals respond to the stimulus sequences is an important step in the validation of the generation method itself. Understanding the degree of variability and prototypical values of each ERP component is crucial to the understanding of typical brain functioning. For this type of technology to be clinically viable in quantifying brain health, the investigators must first quantify the degree to which a healthy brain naturally fluctuates in it processing capability. This study is being carried out to assess how repeatable the ERPs elicited by the new method are while also considering the impact of intraindividual variability observed in previous investigations. Thus, by comparing the results of the scans over time, an assessment of the reliability of the new stimulus sequences can be made. ;

Study Design

Related Conditions & MeSH terms

Brain Health

Clinical Trial Details

NCT number	NCT04661592
Study type	Interventional
Source	NeuroCatch Inc.
Contact
Status	Completed
Phase	N/A
Start date	November 30, 2020
Completion date	August 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04025255` - The Memory and Cognitive Performance Study	N/A
Terminated	`NCT04570995` - Effect of Fish Oil on Athlete's Executive Function	N/A
Completed	`NCT03835962` - Development of a Reference Interval Database With the NeuroCatch™ Platform	N/A
Completed	`NCT02541929` - Fish Oil Brain Delivery Study	Phase 2/Phase 3
Recruiting	`NCT04438967` - Brain Health in the Time of COVID-19
Recruiting	`NCT05912556` - Brain Response to an Intervention Using Guided, At-Home Technology for the Mind	N/A
Active, not recruiting	`NCT04950673` - Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients
Completed	`NCT01334359` - Exercise Effects on Cognition in School-Aged Children	Phase 3
Completed	`NCT04956172` - Assessing the Impact of the NeuroCatch Platform 2 Stimulus Tone Volume	N/A
Completed	`NCT03421405` - Assessing Repeatability of NeuroCatch Platform™ Measurements: An Initial Assessment	N/A
Active, not recruiting	`NCT06027320` - The Retain Your Brain Health Study (RetainYourBrain.Com)	N/A
Completed	`NCT02439983` - Brain Imaging Study	N/A